Terumo Corporation (TRUMY)
USD 19.28
(-2.92%)
USD 19.28
(-2.92%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 106.37 Billion JPY | 19.09% |
| 2023 | 89.32 Billion JPY | 0.58% |
| 2022 | 88.81 Billion JPY | 14.94% |
| 2021 | 77.26 Billion JPY | -9.32% |
| 2020 | 85.21 Billion JPY | 7.22% |
| 2019 | 79.47 Billion JPY | -12.95% |
| 2018 | 91.29 Billion JPY | 65.98% |
| 2017 | 55 Billion JPY | 8.54% |
| 2016 | 50.67 Billion JPY | 31.73% |
| 2015 | 38.47 Billion JPY | 12.83% |
| 2014 | 34.09 Billion JPY | -27.48% |
| 2013 | 47.01 Billion JPY | 94.54% |
| 2012 | 24.16 Billion JPY | -25.27% |
| 2011 | 32.33 Billion JPY | -20.59% |
| 2010 | 40.72 Billion JPY | 10.42% |
| 2009 | 36.87 Billion JPY | -14.99% |
| 2008 | 43.38 Billion JPY | 16.52% |
| 2007 | 37.23 Billion JPY | 14.71% |
| 2006 | 32.45 Billion JPY | 19.62% |
| 2005 | 27.13 Billion JPY | 37.1% |
| 2004 | 19.79 Billion JPY | 9.02% |
| 2003 | 18.15 Billion JPY | 25.72% |
| 2002 | 14.44 Billion JPY | -13.21% |
| 2001 | 16.63 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | 26.47 Billion JPY | -11.17% |
| 2024 Q1 | 22.54 Billion JPY | 17.78% |
| 2024 Q2 | 27.54 Billion JPY | 22.14% |
| 2024 Q3 | 29.8 Billion JPY | 8.22% |
| 2024 FY | 106.37 Billion JPY | 19.09% |
| 2023 Q3 | 29.85 Billion JPY | 66.61% |
| 2023 Q1 | 22.39 Billion JPY | 30.85% |
| 2023 FY | 89.32 Billion JPY | 0.58% |
| 2023 Q4 | 19.14 Billion JPY | -35.88% |
| 2023 Q2 | 17.92 Billion JPY | -19.98% |
| 2022 Q3 | 21.7 Billion JPY | -1.74% |
| 2022 Q4 | 17.11 Billion JPY | -21.15% |
| 2022 Q1 | 27.89 Billion JPY | 49.43% |
| 2022 Q2 | 22.09 Billion JPY | -20.8% |
| 2022 FY | 88.81 Billion JPY | 14.94% |
| 2021 Q4 | 18.66 Billion JPY | -30.24% |
| 2021 FY | 77.26 Billion JPY | -9.32% |
| 2021 Q1 | 14 Billion JPY | -23.56% |
| 2021 Q2 | 17.84 Billion JPY | 27.41% |
| 2021 Q3 | 26.75 Billion JPY | 49.99% |
| 2020 Q2 | 22.91 Billion JPY | 0.56% |
| 2020 FY | 85.21 Billion JPY | 7.22% |
| 2020 Q4 | 18.31 Billion JPY | -13.52% |
| 2020 Q3 | 21.18 Billion JPY | -7.58% |
| 2020 Q1 | 22.79 Billion JPY | -0.8% |
| 2019 Q1 | 18.09 Billion JPY | -34.95% |
| 2019 FY | 79.47 Billion JPY | -12.95% |
| 2019 Q4 | 22.97 Billion JPY | 4.24% |
| 2019 Q3 | 22.04 Billion JPY | 34.71% |
| 2019 Q2 | 16.36 Billion JPY | -9.56% |
| 2018 Q3 | 30.51 Billion JPY | 46.48% |
| 2018 Q1 | 20.33 Billion JPY | -9.23% |
| 2018 FY | 91.29 Billion JPY | 65.98% |
| 2018 Q2 | 20.83 Billion JPY | 2.45% |
| 2018 Q4 | 27.81 Billion JPY | -8.87% |
| 2017 Q4 | 22.4 Billion JPY | 96.53% |
| 2017 Q3 | 11.39 Billion JPY | 10.53% |
| 2017 Q2 | 10.31 Billion JPY | 2.01% |
| 2017 FY | 55 Billion JPY | 8.54% |
| 2017 Q1 | 10.11 Billion JPY | 40.57% |
| 2016 FY | 50.67 Billion JPY | 31.73% |
| 2016 Q1 | 14.5 Billion JPY | 187.55% |
| 2016 Q2 | 12.5 Billion JPY | -13.76% |
| 2016 Q3 | 16.47 Billion JPY | 31.69% |
| 2016 Q4 | 7.19 Billion JPY | -56.34% |
| 2015 FY | 38.47 Billion JPY | 12.83% |
| 2015 Q3 | 11.54 Billion JPY | -14.37% |
| 2015 Q4 | 5.04 Billion JPY | -56.32% |
| 2015 Q1 | 8.39 Billion JPY | 399.79% |
| 2015 Q2 | 13.48 Billion JPY | 60.65% |
| 2014 Q3 | 17.43 Billion JPY | 66.04% |
| 2014 Q4 | -2.8 Billion JPY | -116.06% |
| 2014 FY | 34.09 Billion JPY | -27.48% |
| 2014 Q1 | 8.95 Billion JPY | -59.85% |
| 2014 Q2 | 10.5 Billion JPY | 17.26% |
| 2013 Q1 | 8.15 Billion JPY | 270.02% |
| 2013 Q4 | 22.3 Billion JPY | 119.06% |
| 2013 Q3 | 10.18 Billion JPY | 59.98% |
| 2013 Q2 | 6.36 Billion JPY | -21.99% |
| 2013 FY | 47.01 Billion JPY | 94.54% |
| 2012 Q1 | 9.77 Billion JPY | 101.24% |
| 2012 FY | 24.16 Billion JPY | -25.27% |
| 2012 Q2 | 7.94 Billion JPY | -18.75% |
| 2012 Q4 | 2.2 Billion JPY | -48.12% |
| 2012 Q3 | 4.25 Billion JPY | -46.47% |
| 2011 Q4 | 4.85 Billion JPY | -46.74% |
| 2011 FY | 32.33 Billion JPY | -20.59% |
| 2011 Q3 | 9.11 Billion JPY | -4.73% |
| 2011 Q2 | 9.57 Billion JPY | 8.86% |
| 2011 Q1 | 8.79 Billion JPY | -0.8% |
| 2010 Q1 | 10.81 Billion JPY | 32.94% |
| 2010 FY | 40.72 Billion JPY | 10.42% |
| 2010 Q3 | 11.08 Billion JPY | 11.32% |
| 2010 Q4 | 8.86 Billion JPY | -20.05% |
| 2010 Q2 | 9.95 Billion JPY | -7.89% |
| 2009 FY | 36.87 Billion JPY | -14.99% |
| 2009 Q4 | 8.13 Billion JPY | 41.37% |
| 2009 Q3 | 5.75 Billion JPY | -35.9% |
| 2009 Q2 | 8.97 Billion JPY | 0.0% |
| 2008 FY | 43.38 Billion JPY | 16.52% |
| 2007 FY | 37.23 Billion JPY | 14.71% |
| 2006 FY | 32.45 Billion JPY | 19.62% |
| 2005 FY | 27.13 Billion JPY | 37.1% |
| 2004 FY | 19.79 Billion JPY | 9.02% |
| 2003 FY | 18.15 Billion JPY | 25.72% |
| 2002 FY | 14.44 Billion JPY | -13.21% |
| 2001 FY | 16.63 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | 11476505.583% |
| Ansell Limited | 76.5 Million USD | -138950.98% |
| Ansell Limited | 76.5 Million USD | -138950.98% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 24.28 Million USD | -438010.065% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | 6525139.519% |
| Psykey, Inc. | -1.32 Million USD | 8034687.383% |
| ConvaTec Group Plc | 130.3 Million USD | -81537.759% |
| ConvaTec Group Plc | 130.3 Million USD | -81537.759% |
| Encision Inc. | -691.78 Thousand USD | 15376887.23% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 75011206.332% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | 45388082.899% |
| Innovative MedTech Inc. | -7.93 Million USD | 1340009.058% |
| LifePoint, Inc. | -15.23 Million USD | 698477.196% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 1561897.093% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | 22441872.152% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | 38759637.395% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | 23173849.749% |
| SmileDirectClub, Inc. | -86.4 Million USD | 123212.356% |
| Sector 10, Inc. | 7036.00 USD | -1511853225.753% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | -5213.636% |
| SheerVision, Inc. | -71.37 Thousand USD | 149033388.5% |
| United Health Products, Inc. | -2.62 Million USD | 4055119.943% |
| Vasamed, Inc. | -4.88 Million USD | 2176259.38% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | 4453751.652% |
| Yubo International Biotech Limited | -1.2 Million USD | 8829539.766% |